Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction

BACKGROUNDWe aimed to examine the association between plasminogen activator inhibitor-1 (PAI-1) genetic polymorphism and early spontaneous recanalization in patients presenting with acute ST-elevation myocardial infarction. METHODSPatients admitted to our emergency department with ST-elevation myoca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Coronary artery disease 2013-05, Vol.24 (3), p.196-200
Hauptverfasser: Cagliyan, Caglar E, Yuregir, Ozge O, Balli, Mehmet, Tekin, Kamuran, Akilli, Rabia E, Bozdogan, Sevcan T, Turkmen, Serdar, Deniz, Ali, Baykan, Oytun A, Aslan, Huseyin, Cayli, Murat
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 200
container_issue 3
container_start_page 196
container_title Coronary artery disease
container_volume 24
creator Cagliyan, Caglar E
Yuregir, Ozge O
Balli, Mehmet
Tekin, Kamuran
Akilli, Rabia E
Bozdogan, Sevcan T
Turkmen, Serdar
Deniz, Ali
Baykan, Oytun A
Aslan, Huseyin
Cayli, Murat
description BACKGROUNDWe aimed to examine the association between plasminogen activator inhibitor-1 (PAI-1) genetic polymorphism and early spontaneous recanalization in patients presenting with acute ST-elevation myocardial infarction. METHODSPatients admitted to our emergency department with ST-elevation myocardial infarction in the first 6 h of symptom onset were included. An immediate primary percutaneous coronary intervention was performed. Patients were grouped according to the initial patency of the infarct-related artery (IRA) as followstotal occlusion (TO) group [Thrombolysis in Myocardial Infarction (TIMI) 0–1 flow in the IRA], partial recanalization group (TIMI 2 flow in the IRA), and complete recanalization (CR) group (TIMI 3 flow in the IRA). PAI-1 4G/5G polymorphism was detected using the real-time PCR method. RESULTSThere were 107 patients in the TO group, 30 patients in the partial recanalization group, and 45 patients in the CR group. When we evaluated degrees of patency according to the PAI-1 genotype, TO of the IRA was the highest in patients with the PAI 4G/4G genotype (PAI-1 4G/4G66.7%, PAI-1 4G/5G65.9%, PAI-1 5G/5G40.4%) and CR of the IRA was the highest in patients with the PAI 5G/5G genotype (PAI-1 5G/5G38.5%, PAI-1 4G/5G19.8%, PAI-1 4G/4G17.9%). The distribution of genotypes in different degrees of patency of IRA was statistically significant (P=0.029). In logistic regression analysis, the PAI-1 5G/5G genotype was associated independently with the spontaneous CR of the IRA (odds ratio2.875, 95% confidence interval [1.059–7.086], P=0.038). CONCLUSIONPatients with the PAI-1 5G/5G genotype seem to be luckier than others in terms of early spontaneous recanalization of the IRA. Further prospective studies with large patient populations are required for more precise results.
doi_str_mv 10.1097/MCA.0b013e32835d7633
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1325331000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1325331000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3524-42f4decc4a8a81a4d3d7a85cbfb1c14cf845c2fe7010f92e84b02fe491c7f1643</originalsourceid><addsrcrecordid>eNpdkcFu1DAQhiMEokvhDRDykUtaO7Y3ybFa0aVSEUiUczRxxo3Bawfb6Sq8IK9Vl7QgcbA8M57_G43_onjL6BmjbX3-aXdxRnvKOPKq4XKot5w_KzZM1LyUDafPiw1tpSi3bdWcFK9i_E4pE7KWL4uT6kFCOd0Uv79YiAfj_C06AiqZO0g-EONG05sclYzI_bnck_zu0zIhMZFAjF4ZSDiQo0kjQQh2IXHyLoFDP0cSUIEDa35BMt4Rr0kas9RpCCqVAe0fMYSEYcllMuU-dCmSKWDMgXG3KxrUnJB8vSnR4t0KOyxeQRgM2Cdgrr4uXmiwEd883qfFt8sPN7uP5fXn_dXu4rpUXFaiFJUWAyoloIGGgRj4UEMjVa97pphQuhFSVRpryqhuK2xET3MqWqZqzbaCnxbvV-4U_M8ZY-oOJiq0dl28Y7ySnDNKaW4Va6sKPsaAupuCOUBYOka7Bwu7bGH3v4VZ9u5xwtwfcPgrevLsH_fobf6_-MPORwzdiGDT2OXJrJWUlVXmUpnTMh8q-D3o4a2Z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1325331000</pqid></control><display><type>article</type><title>Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Cagliyan, Caglar E ; Yuregir, Ozge O ; Balli, Mehmet ; Tekin, Kamuran ; Akilli, Rabia E ; Bozdogan, Sevcan T ; Turkmen, Serdar ; Deniz, Ali ; Baykan, Oytun A ; Aslan, Huseyin ; Cayli, Murat</creator><creatorcontrib>Cagliyan, Caglar E ; Yuregir, Ozge O ; Balli, Mehmet ; Tekin, Kamuran ; Akilli, Rabia E ; Bozdogan, Sevcan T ; Turkmen, Serdar ; Deniz, Ali ; Baykan, Oytun A ; Aslan, Huseyin ; Cayli, Murat</creatorcontrib><description>BACKGROUNDWe aimed to examine the association between plasminogen activator inhibitor-1 (PAI-1) genetic polymorphism and early spontaneous recanalization in patients presenting with acute ST-elevation myocardial infarction. METHODSPatients admitted to our emergency department with ST-elevation myocardial infarction in the first 6 h of symptom onset were included. An immediate primary percutaneous coronary intervention was performed. Patients were grouped according to the initial patency of the infarct-related artery (IRA) as followstotal occlusion (TO) group [Thrombolysis in Myocardial Infarction (TIMI) 0–1 flow in the IRA], partial recanalization group (TIMI 2 flow in the IRA), and complete recanalization (CR) group (TIMI 3 flow in the IRA). PAI-1 4G/5G polymorphism was detected using the real-time PCR method. RESULTSThere were 107 patients in the TO group, 30 patients in the partial recanalization group, and 45 patients in the CR group. When we evaluated degrees of patency according to the PAI-1 genotype, TO of the IRA was the highest in patients with the PAI 4G/4G genotype (PAI-1 4G/4G66.7%, PAI-1 4G/5G65.9%, PAI-1 5G/5G40.4%) and CR of the IRA was the highest in patients with the PAI 5G/5G genotype (PAI-1 5G/5G38.5%, PAI-1 4G/5G19.8%, PAI-1 4G/4G17.9%). The distribution of genotypes in different degrees of patency of IRA was statistically significant (P=0.029). In logistic regression analysis, the PAI-1 5G/5G genotype was associated independently with the spontaneous CR of the IRA (odds ratio2.875, 95% confidence interval [1.059–7.086], P=0.038). CONCLUSIONPatients with the PAI-1 5G/5G genotype seem to be luckier than others in terms of early spontaneous recanalization of the IRA. Further prospective studies with large patient populations are required for more precise results.</description><identifier>ISSN: 0954-6928</identifier><identifier>EISSN: 1473-5830</identifier><identifier>DOI: 10.1097/MCA.0b013e32835d7633</identifier><identifier>PMID: 23283030</identifier><language>eng</language><publisher>England: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Adult ; Aged ; Chi-Square Distribution ; Coronary Angiography ; Coronary Occlusion - complications ; Coronary Occlusion - diagnostic imaging ; Coronary Occlusion - genetics ; Coronary Occlusion - physiopathology ; Coronary Occlusion - therapy ; Coronary Vessels - diagnostic imaging ; Coronary Vessels - physiopathology ; Electrocardiography ; Female ; Gene Frequency ; Genetic Predisposition to Disease ; Humans ; Logistic Models ; Male ; Middle Aged ; Myocardial Infarction - diagnostic imaging ; Myocardial Infarction - genetics ; Myocardial Infarction - physiopathology ; Myocardial Infarction - therapy ; Odds Ratio ; Percutaneous Coronary Intervention ; Phenotype ; Plasminogen Activator Inhibitor 1 - genetics ; Polymorphism, Genetic ; Prognosis ; Real-Time Polymerase Chain Reaction ; Risk Factors ; Severity of Illness Index ; Vascular Patency - genetics</subject><ispartof>Coronary artery disease, 2013-05, Vol.24 (3), p.196-200</ispartof><rights>2013 Lippincott Williams &amp; Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3524-42f4decc4a8a81a4d3d7a85cbfb1c14cf845c2fe7010f92e84b02fe491c7f1643</citedby><cites>FETCH-LOGICAL-c3524-42f4decc4a8a81a4d3d7a85cbfb1c14cf845c2fe7010f92e84b02fe491c7f1643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23283030$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cagliyan, Caglar E</creatorcontrib><creatorcontrib>Yuregir, Ozge O</creatorcontrib><creatorcontrib>Balli, Mehmet</creatorcontrib><creatorcontrib>Tekin, Kamuran</creatorcontrib><creatorcontrib>Akilli, Rabia E</creatorcontrib><creatorcontrib>Bozdogan, Sevcan T</creatorcontrib><creatorcontrib>Turkmen, Serdar</creatorcontrib><creatorcontrib>Deniz, Ali</creatorcontrib><creatorcontrib>Baykan, Oytun A</creatorcontrib><creatorcontrib>Aslan, Huseyin</creatorcontrib><creatorcontrib>Cayli, Murat</creatorcontrib><title>Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction</title><title>Coronary artery disease</title><addtitle>Coron Artery Dis</addtitle><description>BACKGROUNDWe aimed to examine the association between plasminogen activator inhibitor-1 (PAI-1) genetic polymorphism and early spontaneous recanalization in patients presenting with acute ST-elevation myocardial infarction. METHODSPatients admitted to our emergency department with ST-elevation myocardial infarction in the first 6 h of symptom onset were included. An immediate primary percutaneous coronary intervention was performed. Patients were grouped according to the initial patency of the infarct-related artery (IRA) as followstotal occlusion (TO) group [Thrombolysis in Myocardial Infarction (TIMI) 0–1 flow in the IRA], partial recanalization group (TIMI 2 flow in the IRA), and complete recanalization (CR) group (TIMI 3 flow in the IRA). PAI-1 4G/5G polymorphism was detected using the real-time PCR method. RESULTSThere were 107 patients in the TO group, 30 patients in the partial recanalization group, and 45 patients in the CR group. When we evaluated degrees of patency according to the PAI-1 genotype, TO of the IRA was the highest in patients with the PAI 4G/4G genotype (PAI-1 4G/4G66.7%, PAI-1 4G/5G65.9%, PAI-1 5G/5G40.4%) and CR of the IRA was the highest in patients with the PAI 5G/5G genotype (PAI-1 5G/5G38.5%, PAI-1 4G/5G19.8%, PAI-1 4G/4G17.9%). The distribution of genotypes in different degrees of patency of IRA was statistically significant (P=0.029). In logistic regression analysis, the PAI-1 5G/5G genotype was associated independently with the spontaneous CR of the IRA (odds ratio2.875, 95% confidence interval [1.059–7.086], P=0.038). CONCLUSIONPatients with the PAI-1 5G/5G genotype seem to be luckier than others in terms of early spontaneous recanalization of the IRA. Further prospective studies with large patient populations are required for more precise results.</description><subject>Adult</subject><subject>Aged</subject><subject>Chi-Square Distribution</subject><subject>Coronary Angiography</subject><subject>Coronary Occlusion - complications</subject><subject>Coronary Occlusion - diagnostic imaging</subject><subject>Coronary Occlusion - genetics</subject><subject>Coronary Occlusion - physiopathology</subject><subject>Coronary Occlusion - therapy</subject><subject>Coronary Vessels - diagnostic imaging</subject><subject>Coronary Vessels - physiopathology</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Gene Frequency</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - diagnostic imaging</subject><subject>Myocardial Infarction - genetics</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial Infarction - therapy</subject><subject>Odds Ratio</subject><subject>Percutaneous Coronary Intervention</subject><subject>Phenotype</subject><subject>Plasminogen Activator Inhibitor 1 - genetics</subject><subject>Polymorphism, Genetic</subject><subject>Prognosis</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Vascular Patency - genetics</subject><issn>0954-6928</issn><issn>1473-5830</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkcFu1DAQhiMEokvhDRDykUtaO7Y3ybFa0aVSEUiUczRxxo3Bawfb6Sq8IK9Vl7QgcbA8M57_G43_onjL6BmjbX3-aXdxRnvKOPKq4XKot5w_KzZM1LyUDafPiw1tpSi3bdWcFK9i_E4pE7KWL4uT6kFCOd0Uv79YiAfj_C06AiqZO0g-EONG05sclYzI_bnck_zu0zIhMZFAjF4ZSDiQo0kjQQh2IXHyLoFDP0cSUIEDa35BMt4Rr0kas9RpCCqVAe0fMYSEYcllMuU-dCmSKWDMgXG3KxrUnJB8vSnR4t0KOyxeQRgM2Cdgrr4uXmiwEd883qfFt8sPN7uP5fXn_dXu4rpUXFaiFJUWAyoloIGGgRj4UEMjVa97pphQuhFSVRpryqhuK2xET3MqWqZqzbaCnxbvV-4U_M8ZY-oOJiq0dl28Y7ySnDNKaW4Va6sKPsaAupuCOUBYOka7Bwu7bGH3v4VZ9u5xwtwfcPgrevLsH_fobf6_-MPORwzdiGDT2OXJrJWUlVXmUpnTMh8q-D3o4a2Z</recordid><startdate>201305</startdate><enddate>201305</enddate><creator>Cagliyan, Caglar E</creator><creator>Yuregir, Ozge O</creator><creator>Balli, Mehmet</creator><creator>Tekin, Kamuran</creator><creator>Akilli, Rabia E</creator><creator>Bozdogan, Sevcan T</creator><creator>Turkmen, Serdar</creator><creator>Deniz, Ali</creator><creator>Baykan, Oytun A</creator><creator>Aslan, Huseyin</creator><creator>Cayli, Murat</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201305</creationdate><title>Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction</title><author>Cagliyan, Caglar E ; Yuregir, Ozge O ; Balli, Mehmet ; Tekin, Kamuran ; Akilli, Rabia E ; Bozdogan, Sevcan T ; Turkmen, Serdar ; Deniz, Ali ; Baykan, Oytun A ; Aslan, Huseyin ; Cayli, Murat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3524-42f4decc4a8a81a4d3d7a85cbfb1c14cf845c2fe7010f92e84b02fe491c7f1643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Chi-Square Distribution</topic><topic>Coronary Angiography</topic><topic>Coronary Occlusion - complications</topic><topic>Coronary Occlusion - diagnostic imaging</topic><topic>Coronary Occlusion - genetics</topic><topic>Coronary Occlusion - physiopathology</topic><topic>Coronary Occlusion - therapy</topic><topic>Coronary Vessels - diagnostic imaging</topic><topic>Coronary Vessels - physiopathology</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Gene Frequency</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - diagnostic imaging</topic><topic>Myocardial Infarction - genetics</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial Infarction - therapy</topic><topic>Odds Ratio</topic><topic>Percutaneous Coronary Intervention</topic><topic>Phenotype</topic><topic>Plasminogen Activator Inhibitor 1 - genetics</topic><topic>Polymorphism, Genetic</topic><topic>Prognosis</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Vascular Patency - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cagliyan, Caglar E</creatorcontrib><creatorcontrib>Yuregir, Ozge O</creatorcontrib><creatorcontrib>Balli, Mehmet</creatorcontrib><creatorcontrib>Tekin, Kamuran</creatorcontrib><creatorcontrib>Akilli, Rabia E</creatorcontrib><creatorcontrib>Bozdogan, Sevcan T</creatorcontrib><creatorcontrib>Turkmen, Serdar</creatorcontrib><creatorcontrib>Deniz, Ali</creatorcontrib><creatorcontrib>Baykan, Oytun A</creatorcontrib><creatorcontrib>Aslan, Huseyin</creatorcontrib><creatorcontrib>Cayli, Murat</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Coronary artery disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cagliyan, Caglar E</au><au>Yuregir, Ozge O</au><au>Balli, Mehmet</au><au>Tekin, Kamuran</au><au>Akilli, Rabia E</au><au>Bozdogan, Sevcan T</au><au>Turkmen, Serdar</au><au>Deniz, Ali</au><au>Baykan, Oytun A</au><au>Aslan, Huseyin</au><au>Cayli, Murat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction</atitle><jtitle>Coronary artery disease</jtitle><addtitle>Coron Artery Dis</addtitle><date>2013-05</date><risdate>2013</risdate><volume>24</volume><issue>3</issue><spage>196</spage><epage>200</epage><pages>196-200</pages><issn>0954-6928</issn><eissn>1473-5830</eissn><abstract>BACKGROUNDWe aimed to examine the association between plasminogen activator inhibitor-1 (PAI-1) genetic polymorphism and early spontaneous recanalization in patients presenting with acute ST-elevation myocardial infarction. METHODSPatients admitted to our emergency department with ST-elevation myocardial infarction in the first 6 h of symptom onset were included. An immediate primary percutaneous coronary intervention was performed. Patients were grouped according to the initial patency of the infarct-related artery (IRA) as followstotal occlusion (TO) group [Thrombolysis in Myocardial Infarction (TIMI) 0–1 flow in the IRA], partial recanalization group (TIMI 2 flow in the IRA), and complete recanalization (CR) group (TIMI 3 flow in the IRA). PAI-1 4G/5G polymorphism was detected using the real-time PCR method. RESULTSThere were 107 patients in the TO group, 30 patients in the partial recanalization group, and 45 patients in the CR group. When we evaluated degrees of patency according to the PAI-1 genotype, TO of the IRA was the highest in patients with the PAI 4G/4G genotype (PAI-1 4G/4G66.7%, PAI-1 4G/5G65.9%, PAI-1 5G/5G40.4%) and CR of the IRA was the highest in patients with the PAI 5G/5G genotype (PAI-1 5G/5G38.5%, PAI-1 4G/5G19.8%, PAI-1 4G/4G17.9%). The distribution of genotypes in different degrees of patency of IRA was statistically significant (P=0.029). In logistic regression analysis, the PAI-1 5G/5G genotype was associated independently with the spontaneous CR of the IRA (odds ratio2.875, 95% confidence interval [1.059–7.086], P=0.038). CONCLUSIONPatients with the PAI-1 5G/5G genotype seem to be luckier than others in terms of early spontaneous recanalization of the IRA. Further prospective studies with large patient populations are required for more precise results.</abstract><cop>England</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>23283030</pmid><doi>10.1097/MCA.0b013e32835d7633</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0954-6928
ispartof Coronary artery disease, 2013-05, Vol.24 (3), p.196-200
issn 0954-6928
1473-5830
language eng
recordid cdi_proquest_miscellaneous_1325331000
source MEDLINE; Journals@Ovid Complete
subjects Adult
Aged
Chi-Square Distribution
Coronary Angiography
Coronary Occlusion - complications
Coronary Occlusion - diagnostic imaging
Coronary Occlusion - genetics
Coronary Occlusion - physiopathology
Coronary Occlusion - therapy
Coronary Vessels - diagnostic imaging
Coronary Vessels - physiopathology
Electrocardiography
Female
Gene Frequency
Genetic Predisposition to Disease
Humans
Logistic Models
Male
Middle Aged
Myocardial Infarction - diagnostic imaging
Myocardial Infarction - genetics
Myocardial Infarction - physiopathology
Myocardial Infarction - therapy
Odds Ratio
Percutaneous Coronary Intervention
Phenotype
Plasminogen Activator Inhibitor 1 - genetics
Polymorphism, Genetic
Prognosis
Real-Time Polymerase Chain Reaction
Risk Factors
Severity of Illness Index
Vascular Patency - genetics
title Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A50%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasminogen%20activator%20inhibitor-1%205G/5G%20genotype%20is%20associated%20with%20early%20spontaneous%20recanalization%20of%20the%20infarct-related%20artery%20in%20patients%20presenting%20with%20acute%20ST-elevation%20myocardial%20infarction&rft.jtitle=Coronary%20artery%20disease&rft.au=Cagliyan,%20Caglar%20E&rft.date=2013-05&rft.volume=24&rft.issue=3&rft.spage=196&rft.epage=200&rft.pages=196-200&rft.issn=0954-6928&rft.eissn=1473-5830&rft_id=info:doi/10.1097/MCA.0b013e32835d7633&rft_dat=%3Cproquest_cross%3E1325331000%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1325331000&rft_id=info:pmid/23283030&rfr_iscdi=true